U.S. DOD/CDMRP: Peer Reviewed Medical Research Program (PRMRP) – COVID-19 (for Emerging Viral Diseases and Respiratory Health– Pre-proposals

* Clinical Trial Award: Supports the rapid implementation of clinical trials of novel interventions with the potential to have a significant impact on patient care in EVD/RH. Must address at least one of the Focus Areas. May range from small proof-of-concept trials through large-scale, definitive trials. IND or IDE applications to the FDA, if needed, should be submitted to the FDA before the PRMRP application submission deadline.  Funding: not defined, must be appropriate for the scope. Maximum period of performance is 4 years.

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=256400